{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:56:45Z","timestamp":1790553405757,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06223-8","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:26:28Z","timestamp":1783175188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ten-year trends in cardiovascular risk factors among patients hospitalised with acute myocardial infarction in Estonia: a retrospective nationwide observational study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7000-0590","authenticated-orcid":false,"given":"Abdulrahman","family":"Al-Dawoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2798-1163","authenticated-orcid":false,"given":"Mujahed","family":"Dalain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0125-0240","authenticated-orcid":false,"given":"Daniil","family":"Varlamov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0282-502X","authenticated-orcid":false,"given":"Shaghaf","family":"Alhallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9664-6046","authenticated-orcid":false,"given":"Michele","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"17","key":"6223_CR1","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.3390\/jcm14176241","volume":"14","author":"T Saha","year":"2025","unstructured":"Saha T, Soliman-Aboumarie H. Review of Current Management of Myocardial Infarction. J Clin Med. 2025;14(17):6241. https:\/\/doi.org\/10.3390\/jcm14176241.","journal-title":"J Clin Med"},{"issue":"1","key":"6223_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","volume":"23","author":"N Salari","year":"2023","unstructured":"Salari N, Morddarvanjoghi F, Abdolmaleki A, et al. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023;23(1):206. https:\/\/doi.org\/10.1186\/s12872-023-03231-w.","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"6223_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jamacardio.2022.0662","volume":"7","author":"Y Wang","year":"2022","unstructured":"Wang Y, Leifheit EC, Krumholz HM. Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction. JAMA Cardiol. 2022;7(6):613\u201322. https:\/\/doi.org\/10.1001\/jamacardio.2022.0662.","journal-title":"JAMA Cardiol"},{"issue":"12","key":"6223_CR4","doi-asserted-by":"publisher","first-page":"e0167623","DOI":"10.1371\/journal.pone.0167623","volume":"11","author":"M Sardarinia","year":"2016","unstructured":"Sardarinia M, Akbarpour S, Lotfaliany M, et al. Risk factors for incidence of cardiovascular diseases and all-cause mortality in a Middle Eastern population over a decade follow-up: Tehran Lipid and Glucose Study. PLoS ONE. 2016;11(12):e0167623. https:\/\/doi.org\/10.1371\/journal.pone.0167623.","journal-title":"PLoS ONE"},{"key":"6223_CR5","doi-asserted-by":"publisher","first-page":"154838","DOI":"10.1016\/j.metabol.2021.154838","volume":"123","author":"JS Yun","year":"2021","unstructured":"Yun JS, Ko SH. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes. Metabolism. 2021;123:154838. https:\/\/doi.org\/10.1016\/j.metabol.2021.154838.","journal-title":"Metabolism"},{"issue":"8","key":"6223_CR6","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/eurjpc\/zwae025","volume":"31","author":"A Welsh","year":"2024","unstructured":"Welsh A, Hammad M, Pi\u00f1a IL, et al. Obesity and cardiovascular health. Eur J Prev Cardiol. 2024;31(8):1026\u201335. https:\/\/doi.org\/10.1093\/eurjpc\/zwae025.","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"6223_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/eurjpc\/zwab134","volume":"29","author":"F Vancheri","year":"2022","unstructured":"Vancheri F, Tate AR, Henein M, et al. Time trends in ischaemic heart disease incidence and mortality over three decades (1990\u20132019) in 20 Western European countries: systematic analysis of the Global Burden of Disease Study 2019. Eur J Prev Cardiol. 2022;29(2):396\u2013403. https:\/\/doi.org\/10.1093\/eurjpc\/zwab134.","journal-title":"Eur J Prev Cardiol"},{"key":"6223_CR8","doi-asserted-by":"publisher","DOI":"10.1787\/ea7a15f4-en","volume-title":"The State of Cardiovascular Health in the European Union","author":"OECD","year":"2025","unstructured":"OECD. The State of Cardiovascular Health in the European Union. Paris: OECD Publishing; 2025. https:\/\/doi.org\/10.1787\/ea7a15f4-en."},{"issue":"1","key":"6223_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5334\/aogh.2713","volume":"86","author":"NK Movsisyan","year":"2020","unstructured":"Movsisyan NK, Vinciguerra M, Medina-Inojosa JR, et al. Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion. Ann Glob Health. 2020;86(1):21. https:\/\/doi.org\/10.5334\/aogh.2713.","journal-title":"Ann Glob Health"},{"key":"6223_CR10","doi-asserted-by":"publisher","first-page":"104710","DOI":"10.1016\/j.healthpol.2023.104710","volume":"130","author":"T Habicht","year":"2023","unstructured":"Habicht T, Kasekamp K, Webb E. 30 years of primary health care reforms in Estonia: The role of financial incentives to achieve a multidisciplinary primary health care system. Health Policy. 2023;130:104710. https:\/\/doi.org\/10.1016\/j.healthpol.2023.104710.","journal-title":"Health Policy"},{"key":"6223_CR11","unstructured":"National Institute for Health Development. Acute myocardial infarction: definitions and methodology. Estonian Health Statistics and Health Research Database. 2025. https:\/\/statistika.tai.ee\/pxweb\/en\/Andmebaas\/. Accessed 3 June 2026."},{"issue":"16","key":"6223_CR12","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.3390\/jcm14165752","volume":"14","author":"J Sacramento-Pacheco","year":"2025","unstructured":"Sacramento-Pacheco J, S\u00e1nchez-G\u00f3mez MB, Duarte-Cl\u00edments G, et al. Prevalence of Cardiovascular Risk Factors Among Adults in the European Union: A Systematic Review with Meta-Analysis. J Clin Med. 2025;14(16):5752. https:\/\/doi.org\/10.3390\/jcm14165752.","journal-title":"J Clin Med"},{"key":"6223_CR13","doi-asserted-by":"publisher","unstructured":"Stolpe S, Stolpe S. Heterogeneous courses of cardiovascular disease incidence in Europe 2000\u20132019: what are the causes? Eur J Public Health. 2024;34(Suppl 3):ckae144.866. https:\/\/doi.org\/10.1093\/eurpub\/ckae144.866.","DOI":"10.1093\/eurpub\/ckae144.866"},{"key":"6223_CR14","doi-asserted-by":"publisher","first-page":"e57840","DOI":"10.2196\/57840","volume":"10","author":"S Mubarik","year":"2024","unstructured":"Mubarik S, Naeem S, Shen H, et al. Population-Level Distribution, Risk Factors, and Burden of Mortality and Disability-Adjusted Life Years Attributable to Major Noncommunicable Diseases in Western Europe (1990\u20132021): Ecological Analysis. JMIR Public Health Surveill. 2024;10:e57840. https:\/\/doi.org\/10.2196\/57840.","journal-title":"JMIR Public Health Surveill"},{"key":"6223_CR15","doi-asserted-by":"publisher","first-page":"101079","DOI":"10.1016\/j.lanepe.2024.101079","volume":"47","author":"A Cherla","year":"2024","unstructured":"Cherla A, Kyriopoulos I, Pearcy P, et al. Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995\u20132020: a retrospective secondary data analysis. Lancet Reg Health Eur. 2024;47:101079. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101079.","journal-title":"Lancet Reg Health Eur"},{"key":"6223_CR16","doi-asserted-by":"publisher","first-page":"100718","DOI":"10.1016\/j.lanepe.2023.100718","volume":"33","author":"A Timmis","year":"2023","unstructured":"Timmis A, Kazakiewicz D, Torbica A, et al. Cardiovascular disease care and outcomes in West and South European countries. Lancet Reg Health Eur. 2023;33:100718. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100718.","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"6223_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/13418","volume":"10","author":"A Starker","year":"2025","unstructured":"Starker A, M\u00f6\u00dfnang D. Placing smoking prevalence in the context of tobacco control measures in Europe. J Health Monit. 2025;10(3):3\u201314. https:\/\/doi.org\/10.25646\/13418.","journal-title":"J Health Monit"},{"key":"6223_CR18","unstructured":"Reinap M. Stricter tobacco and alcohol regulations in Estonia. European Observatory on Health Systems and Policies, Health Systems and Policy Monitor. 2019. https:\/\/eurohealthobservatory.who.int\/monitors\/health-systems-monitor\/updates\/hspm\/estonia-2018\/stricter-tobacco-and-alcohol-regulations-in-estonia. Accessed 3 June 2026."},{"key":"6223_CR19","unstructured":"OECD\/European Observatory on Health Systems and Policies. Estonia: Country Health Profile 2023. State of Health in the EU. OECD Publishing, Paris\/European Observatory on Health Systems and Policies, Brussels; 2023. https:\/\/health.ec.europa.eu\/state-health-eu\/country-health-profiles\/country-health-profiles-2023_en. Accessed 3 June 2026."},{"issue":"14","key":"6223_CR20","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/eurjpc\/zwad077","volume":"30","author":"T Mahendiran","year":"2023","unstructured":"Mahendiran T, Hoepli A, Foster-Witassek F, et al. Twenty-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland. Eur J Prev Cardiol. 2023;30(14):1504\u201312. https:\/\/doi.org\/10.1093\/eurjpc\/zwad077.","journal-title":"Eur J Prev Cardiol"},{"key":"6223_CR21","doi-asserted-by":"publisher","first-page":"100824","DOI":"10.1016\/j.lanepe.2023.100824","volume":"38","author":"R Bugiardini","year":"2024","unstructured":"Bugiardini R, Cenko E, Yoon J, et al. Traditional risk factors and premature acute coronary syndromes in South Eastern Europe: a multinational cohort study. Lancet Reg Health Eur. 2024;38:100824. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100824.","journal-title":"Lancet Reg Health Eur"},{"issue":"9438","key":"6223_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, \u00d4unpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(04)17018-9.","journal-title":"Lancet"},{"key":"6223_CR23","doi-asserted-by":"publisher","first-page":"1264319","DOI":"10.3389\/fcvm.2023.1264319","volume":"10","author":"E Reijnders","year":"2023","unstructured":"Reijnders E, Van Der Laarse A, Jukema JW, et al. High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine. Front Cardiovasc Med. 2023;10:1264319. https:\/\/doi.org\/10.3389\/fcvm.2023.1264319.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"6223_CR24","doi-asserted-by":"publisher","first-page":"103712","DOI":"10.1016\/j.numecd.2024.08.006","volume":"35","author":"C Tognola","year":"2025","unstructured":"Tognola C, Intravaia RCM, Senini E, Pezzoli S, Riccio A, Gualini E, et al. Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement. Nutr Metab Cardiovasc Dis. 2025;35(2):103712. https:\/\/doi.org\/10.1016\/j.numecd.2024.08.006.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"6223_CR25","doi-asserted-by":"publisher","first-page":"133608","DOI":"10.1016\/j.ijcard.2025.133608","volume":"439","author":"C Tognola","year":"2025","unstructured":"Tognola C, Bernasconi D, Intravaia RCM, Brioschi G, Toscani G, Algeri M, et al. Prevalence of hypertriglyceridemia and its association with extreme cardiovascular risk in patients with acute and chronic coronary syndrome enrolled in a cardiac rehabilitation program. Int J Cardiol. 2025;439:133608. https:\/\/doi.org\/10.1016\/j.ijcard.2025.133608.","journal-title":"Int J Cardiol"},{"issue":"3","key":"6223_CR26","doi-asserted-by":"publisher","first-page":"bvag001","DOI":"10.1210\/jendso\/bvag001","volume":"10","author":"F Di Giacomo Barbagallo","year":"2026","unstructured":"Di Giacomo Barbagallo F, Bosco G, Di Marco M, Scilletta S, Miano N, Martedi M, et al. Assessment of N\/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation. J Endocr Soc. 2026;10(3):bvag001. https:\/\/doi.org\/10.1210\/jendso\/bvag001.","journal-title":"J Endocr Soc"},{"key":"6223_CR27","doi-asserted-by":"publisher","unstructured":"Di Giacomo Barbagallo F, Gonzalez-Lleo A, Amigo N, Bosco G, Ibarretxe D, Piro S, et al. Prevalence of elevated lipoprotein(a) levels and associated atherosclerotic cardiovascular diseases in subjects with metabolic disorders: a real-world study in a lipid unit. Clin Investig Arterioscler. 2026;500892. https:\/\/doi.org\/10.1016\/j.arteri.2026.500892.","DOI":"10.1016\/j.arteri.2026.500892"},{"issue":"5","key":"6223_CR28","doi-asserted-by":"publisher","first-page":"e59663","DOI":"10.7759\/cureus.59663","volume":"16","author":"D Betai","year":"2024","unstructured":"Betai D, Ahmed AS, Saxena P, et al. Gender disparities in cardiovascular disease and their management: a review. Cureus. 2024;16(5):e59663. https:\/\/doi.org\/10.7759\/cureus.59663.","journal-title":"Cureus"},{"issue":"20","key":"6223_CR29","doi-asserted-by":"publisher","first-page":"e030203","DOI":"10.1161\/JAHA.123.030203","volume":"12","author":"Y Wang","year":"2023","unstructured":"Wang Y, Tian A, Wu C, et al. Influence of Socioeconomic Gender Inequality on Sex Disparities in Prevention and Outcome of Cardiovascular Disease: Data From a Nationwide Population Cohort in China. J Am Heart Assoc. 2023;12(20):e030203. https:\/\/doi.org\/10.1161\/JAHA.123.030203.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"6223_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5334\/gh.1485","volume":"20","author":"SC De Ruiter","year":"2025","unstructured":"De Ruiter SC, Tschiderer L, Grobbee DE, et al. Smoking as a Risk Factor for Cardiovascular Disease in Females and Males: Observational and Mendelian Randomisation Analyses in the UK Biobank. Glob Heart. 2025;20(1):93. https:\/\/doi.org\/10.5334\/gh.1485.","journal-title":"Glob Heart"},{"key":"6223_CR31","doi-asserted-by":"publisher","first-page":"108013","DOI":"10.1016\/j.ypmed.2024.108013","volume":"188","author":"DE Gaalema","year":"2024","unstructured":"Gaalema DE, Allencherril J, Khadanga S, et al. Differential effects of cigarette smoking on cardiovascular disease in females: A narrative review and call to action. Prev Med. 2024;188:108013. https:\/\/doi.org\/10.1016\/j.ypmed.2024.108013.","journal-title":"Prev Med"},{"issue":"13","key":"6223_CR32","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/eurjpc\/zwaf237","volume":"32","author":"K Whitmore","year":"2025","unstructured":"Whitmore K, Zhou Z, Magnussen CG, et al. Review of strategies to improve adherence to lipid-lowering therapy in the primary prevention of cardiovascular disease. Eur J Prev Cardiol. 2025;32(13):1204\u201315. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf237.","journal-title":"Eur J Prev Cardiol"},{"issue":"16","key":"6223_CR33","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1093\/eurjpc\/zwad214","volume":"30","author":"M Zuin","year":"2023","unstructured":"Zuin M, Rigatelli G, Temporelli P, et al. Trends in acute myocardial infarction mortality in the European Union, 2012\u20132020. Eur J Prev Cardiol. 2023;30(16):1758\u201371. https:\/\/doi.org\/10.1093\/eurjpc\/zwad214.","journal-title":"Eur J Prev Cardiol"},{"issue":"42","key":"6223_CR34","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","volume":"46","author":"F Mach","year":"2025","unstructured":"Mach F, Koskinas KC, Van Roeters JE, et al. 2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2025;46(42):4359\u201378. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf190.","journal-title":"Eur Heart J"},{"key":"6223_CR35","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.ajpc.2025.101069","volume":"24","author":"A Lala","year":"2025","unstructured":"Lala A, Beavers C, Blumer V, et al. The continuum of prevention and heart failure in cardiovascular medicine: A joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology. Am J Prev Cardiol. 2025;24:101069. https:\/\/doi.org\/10.1016\/j.ajpc.2025.101069.","journal-title":"Am J Prev Cardiol"},{"issue":"2","key":"6223_CR36","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ije\/dyn359","volume":"38","author":"SV Subramanian","year":"2009","unstructured":"Subramanian SV, Jones K, Kaddour A, et al. Revisiting Robinson: The perils of individualistic and ecologic fallacy. Int J Epidemiol. 2009;38(2):342\u201360. https:\/\/doi.org\/10.1093\/ije\/dyn359.","journal-title":"Int J Epidemiol"},{"issue":"619","key":"6223_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3399\/bjgp14X676979","volume":"64","author":"C Saunders","year":"2014","unstructured":"Saunders C, Abel G. Ecological studies: use with caution. Br J Gen Pract. 2014;64(619):65\u20136. https:\/\/doi.org\/10.3399\/bjgp14X676979.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"6223_CR38","doi-asserted-by":"publisher","first-page":"e101381","DOI":"10.1136\/bmjhci-2024-101381","volume":"32","author":"J Pan","year":"2025","unstructured":"Pan J, Lee S, Cheligeer C, et al. Assessing the validity of ICD-10 administrative data in coding comorbidities. BMJ Health Care Inf. 2025;32(1):e101381. https:\/\/doi.org\/10.1136\/bmjhci-2024-101381.","journal-title":"BMJ Health Care Inf"},{"key":"6223_CR39","doi-asserted-by":"publisher","first-page":"648290","DOI":"10.3389\/fcvm.2021.648290","volume":"8","author":"O Toscano","year":"2021","unstructured":"Toscano O, Cosentino N, Campodonico J, Bartorelli AL, Marenzi G. Acute myocardial infarction during the COVID-19 pandemic: an update on clinical characteristics and outcomes. Front Cardiovasc Med. 2021;8:648290. https:\/\/doi.org\/10.3389\/fcvm.2021.648290.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"6223_CR40","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1080\/02664763.2022.2063265","volume":"50","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Chen HS, Midthune D, et al. Data-driven choice of a model selection method in joinpoint regression. J Appl Stat. 2023;50(9):1992\u20132013. https:\/\/doi.org\/10.1080\/02664763.2022.2063265.","journal-title":"J Appl Stat"},{"issue":"4","key":"6223_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/17453674.2019.1612624","volume":"90","author":"J Ranstam","year":"2019","unstructured":"Ranstam J. Hypothesis-generating and confirmatory studies, Bonferroni correction, and pre-specification of trial endpoints. Acta Orthop. 2019;90(4):297\u2013297. https:\/\/doi.org\/10.1080\/17453674.2019.1612624.","journal-title":"Acta Orthop"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06223-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06223-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06223-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:53:48Z","timestamp":1790553228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06223-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6223"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06223-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study utilised publicly available, anonymised, aggregated data obtained from the Estonian Health Statistics and Health Research Database (National Institute for Health Development, Estonia), including AMI01, AMI02, AMI04, TKU50, TKU40, and ETU30 tables. No individual-level patient identifiers were available to the investigators. In accordance with national regulations governing the use of publicly accessible aggregated health statistics data, formal ethics committee approval and individual informed consent to participate were not required. All methods were carried out in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"847"}}